Cash Flow Statement

Amortizatization of Intangibles Cash from Financing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Cash Change in Inventory Change in Receivables Deferred Taxes Free Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other financing activities Shares Issued

Growth Metrics

Others

Goldenwell Biotech (GWLL) Asset Writedowns and Impairment (2021 - 2023)

Goldenwell Biotech (GWLL) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $711.0 as the latest value for Q1 2023.